Form 8-K - Current report:
SEC Accession No. 0001213900-24-112016
Filing Date
2024-12-23
Accepted
2024-12-23 17:14:50
Documents
26
Period of Report
2024-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0225663-8k_neupho.htm   iXBRL 8-K 61764
2 SCHEME IMPLEMENTATION AGREEMENT, DATED OCTOBER 1, 2024, BETWEEN BIONOMICS LIMITE ea022566301ex2-1_neupho.htm EX-2.1 553643
3 AMENDING AGREEMENT TO SCHEME IMPLEMENTATION AGREEMENT, DATED OCTOBER 24, 2024, B ea022566301ex2-2_neupho.htm EX-2.2 140820
4 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS FILED WITH THE SECRETARY O ea022566301ex3-1_neupho.htm EX-3.1 41512
5 BYLAWS, DATED AUGUST 2, 2024 ea022566301ex3-2_neupho.htm EX-3.2 147289
6 FORM OF INDEMNIFICATION AGREEMENT ea022566301ex10-1_neupho.htm EX-10.1 85601
7 NEUPHORIA THERAPEUTICS INC. 2024 EQUITY INCENTIVE PLAN ea022566301ex10-2_neupho.htm EX-10.2 177251
8 CODE OF CONDUCT ea022566301ex14-1_neupho.htm EX-14.1 65348
9 DESCRIPTION OF CAPITAL STOCK ea022566301ex99-1_neupho.htm EX-99.1 24855
10 PRESS RELEASE, DATED DECEMBER 23, 2024 ea022566301ex99-2_neupho.htm EX-99.2 10222
14 GRAPHIC ex2-1_001.jpg GRAPHIC 5341
15 GRAPHIC ex2-1_002.jpg GRAPHIC 1915
16 GRAPHIC ex14-1_001.jpg GRAPHIC 8933
17 GRAPHIC ex99-2_001.jpg GRAPHIC 6497
  Complete submission text file 0001213900-24-112016.txt   1731666

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE bnox-20241223.xsd EX-101.SCH 3027
12 XBRL LABEL FILE bnox-20241223_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE bnox-20241223_pre.xml EX-101.PRE 22367
29 EXTRACTED XBRL INSTANCE DOCUMENT ea0225663-8k_neupho_htm.xml XML 3792
Mailing Address 200 GREENHILL ROAD EASTWOOD SA C3 5063
Business Address 200 GREENHILL ROAD EASTWOOD SA C3 5063 61 8 8150 7400
BIONOMICS LIMITED/FI (Filer) CIK: 0001191070 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41157 | Film No.: 241574845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)